| AstraZeneca Continues to Support Patients on CRESTOR® (EN, CNX) |
| AstraZeneca looks to revive experimental drugs (EN, Financial Times) |
| IT Takes Charge at AstraZeneca (EN, The Wall Street Journal Deutschland) |
| AstraZeneca Needs New Strategy After Boardroom Shake up - EP VantageInvestigates (EN, CNX) |
| CFO Moves: AstraZeneca, Republic Services, Allscripts, Ingram Micro (EN, The Wall Street Journal Deutschland) |
| AstraZeneca CEO to Exit (EN, Wall Street Journal Europe) |
| AstraZeneca C.E.O. to Step Down (EN, New York Times) |
| AstraZeneca Still at Sea as CEO Jumps Ship (EN, The Wall Street Journal Deutschland) |
| Boardroom Revolt at AstraZeneca (EN, MotleyFool) |
| AstraZeneca chief to stand down (EN, BBC) |
| London Markets: Shell results lift FTSE 100, AstraZeneca off (EN, MarketWatch) |
| AstraZeneca CEO to step down as Q1 profit plunges (EN, Yahoo) |
| AstraZeneca: Klarer Ergebnisrückgang im ersten Quartal, CEO tritt zurück (Aktiencheck) |
| AstraZeneca limits gains on FTSE 100 (EN, Financial Times) |
| Boardroom 'coup' at AstraZeneca (EN, BBC) |
| Brennan to retire as AstraZeneca chief (EN, Financial Times) |
| AstraZeneca CEO Leaving as Profits Slide (EN, The Wall Street Journal Deutschland) |
| Options Player Hits Jackpot On AstraZeneca Ardea Deal, Bulls Pour Into Ambev (EN, Forbes) |
| AstraZeneca to buy biotech company Ardea Biosciences for US$1.26 billion (EN, Chinapost) |
| AstraZeneca Seals $1.26 Billion Ardea Deal (EN, Wall Street Journal Europe) |
| AstraZeneca Buys Ardea Biosciences for $1.26 Billion: Hot Trends (EN, TheStreet.com) |
| DealBook: AstraZeneca Reaches $1.26 Billion Deal for Ardea Biosciences (EN, New York Times) |
| AstraZeneca Buys Ardea Biosciences for $1.26B: Hot Trends (EN, TheStreet.com) |
| AstraZeneca to pay $1.3bn for Ardea (EN, Financial Times) |
| Is AstraZeneca Pharma’s Best Kept Secret? (EN, MotleyFool) |
| AstraZeneca: Übernahme von Ardea Biosciences (Aktiencheck) |
| AstraZeneca Seals $1.26 Billion Ardea Deal (EN, The Wall Street Journal Deutschland) |
| AstraZeneca startet Biotech-Zukauf (The Wall Street Journal Deutschland) |
| AstraZeneca will Biotechnologieunternehmen für Milliardensumme kaufen (dpa-afx) |
| AstraZeneca Needs the Right Formula (EN, MotleyFool) |
| AstraZeneca faces calls for shake-up (EN, Financial Times) |
| Amgen, AstraZeneca to Work on Inflammation Drugs (EN, The Wall Street Journal Deutschland) |
| Amgen, AstraZeneca team on 5 experimental drugs (EN, Market Watch) |
| AstraZeneca Wins Patent Protection on Seroquel: Hot Trends (EN, TheStreet.com) |
| AstraZeneca: U.S. ruling over Seroquel favorable (EN, Market Watch) |
| AstraZeneca Delivers Glum News to Investors (EN, The Wall Street Journal Deutschland) |
| AstraZeneca chief’s total pay surges (EN, Financial Times) |
| AstraZeneca Faces Depressing Outlook (EN, The Wall Street Journal Deutschland) |
| AstraZeneca Fails in U.S. Seroquel Bid (EN, Wall Street Journal Europe) |
| AstraZeneca Loses U.S. Seroquel Suit (EN, The Wall Street Journal Deutschland) |